Defendant entity record
Purdue Pharma lawsuits
OxyContin maker; twice a federal felon — 2007 misbranding, 2020 fraud and kickback conspiracies — with a $5.5 billion criminal sentence imposed in 2026 within the opioid settlement architecture.
Claims in these lawsuits are allegations until a court or settlement resolves them.
Key facts
| Cases we track | 0 |
|---|
The entity record
- Fact 1
- 2 — federal felony guilty pleas (2007 misbranding; 2020 fraud/kickbacks)
- Source: https://www.justice.gov/archives/opa/pr/opioid-manufacturer-purdue-pharma-pleads-guilty-fraud-and-kickback-conspiracies
- Fact 2
- $5.5B — criminal sentence imposed April 2026
- Source: https://www.justice.gov/
- Fact 3
- 76B — opioid pills in the ARCOS data unsealed via the MDL
- Source: https://www.washingtonpost.com/
Purdue's criminal record is adjudicated fact, not allegation: in 2007 the company pleaded guilty to felony misbranding of OxyContin — marketing it as less addictive while knowing its abuse potential resembled morphine — and in 2020 pleaded guilty again to fraud and kickback conspiracies.
The national opioid litigation surrounding Purdue produced one of the great transparency outcomes in mass-tort history: court fights led by news organizations unsealed the DEA's ARCOS shipment database — 76 billion opioid pills tracked to the county level — and settlement terms created the public Opioid Industry Documents Archive.
Purdue's bankruptcy has been litigated to the Supreme Court and back over releases for the Sackler family; the plan architecture continued evolving through 2026. Docket specifics belong to the bankruptcy court record.
Public-record events
Apr 15, 2026 · Ruling
$5.5B sentence imposed within the opioid settlement architecture.
View source ↗Oct 21, 2020 · Ruling
Purdue pleads guilty to fraud and kickback conspiracies.
View source ↗Jun 20, 2019 · Ruling
Sixth Circuit ruling (press-led) forces unsealing of the ARCOS opioid shipment database.
View source ↗May 10, 2007 · Ruling
Purdue pleads guilty to felony misbranding of OxyContin.
View source ↗